documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
41,555 rows where posted_year = 2019 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Supporting & Related Material 23,800
- Other 14,105
- Notice 2,291
- Proposed Rule 720
- Rule 639
posted_year 1
- 2019 · 41,555 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA-R04-OAR-2018-0792-0014 | EPA | EPA-R04-OAR-2018-0792 | Ascend -12-2-19 ADEM email | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:39:54Z | 0 | 0 | 0900006484204be2 | ||||
| EPA-R04-OAR-2018-0792-0011 | EPA | EPA-R04-OAR-2018-0792 | 06-18-2015 2014 EMIS INV | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:39:29Z | 0 | 0 | 09000064841f0490 | ||||
| EPA-R04-OAR-2018-0792-0008 | EPA | EPA-R04-OAR-2018-0792 | 2016-AirEmissionsReport-2 | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:38:40Z | 0 | 0 | 09000064841f05ac | ||||
| EPA-R09-OAR-2019-0598-0002 | EPA | EPA-R09-OAR-2019-0598 | Docket Index - Oscar Renda Contracting, Inc. General Permit | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:42:03Z | 0 | 0 | 090000648425c468 | ||||
| EPA-R04-OAR-2018-0792-0010 | EPA | EPA-R04-OAR-2018-0792 | BEC Flare Hr 2013-2015 | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:39:42Z | 0 | 0 | 09000064841f0488 | ||||
| EPA-R04-OAR-2018-0792-0006 | EPA | EPA-R04-OAR-2018-0792 | AL Cover Letter September 5-2019 | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:39:05Z | 0 | 0 | 09000064841f05aa | ||||
| EPA-R04-OAR-2018-0792-0007 | EPA | EPA-R04-OAR-2018-0792 | Responses to EPA re Alabama SO2 Transport | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:38:53Z | 0 | 0 | 09000064841f05ab | ||||
| EPA-R08-OAR-2018-0380-0012 | EPA | EPA-R08-OAR-2018-0380 | Email Notif Final Permit to Affected States and Stakeholders | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:41:32Z | 0 | 0 | 090000648425f13f | ||||
| EPA-R04-OAR-2018-0792-0002 | EPA | EPA-R04-OAR-2018-0792 | AL-SO2-Transport-SIP-Admin-Part1 | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:40:31Z | 0 | 0 | 09000064838ea155 | ||||
| EPA-R09-OAR-2019-0598-0006 | EPA | EPA-R09-OAR-2019-0598 | Approval for Oscar Renda Contracting, Inc. Portable Concrete Batch Plant Facility General Permit | Other | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2020-01-01T01:42:18Z | 0 | 0 | 090000648425c469 | |||
| EPA-R09-OAR-2019-0598-0004 | EPA | EPA-R09-OAR-2019-0598 | Section 2 - Final Permit and Related Documents | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:42:48Z | 0 | 0 | 090000648425bb19 | ||||
| EPA-R04-OAR-2018-0792-0012 | EPA | EPA-R04-OAR-2018-0792 | 06-25-2014 2013 EMIS INV | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:39:17Z | 0 | 0 | 09000064841f0491 | ||||
| EPA-R04-OAR-2018-0792-0009 | EPA | EPA-R04-OAR-2018-0792 | 01-28-2016 -CMS-FLARE RPT | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:38:27Z | 0 | 0 | 09000064841f05ad | ||||
| EPA-R04-OAR-2018-0792-0015 | EPA | EPA-R04-OAR-2018-0792 | AL-117-PR-TSD-Escambia | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:38:03Z | 0 | 0 | 090000648420cf5c | ||||
| EPA-HQ-OPP-2013-0153-0043 | EPA | EPA-HQ-OPP-2013-0153 | Aerobic Degradation of Chloropicrin in Aquatic Systems Data Evaluation Record (DER) | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:35:37Z | 0 | 0 | 0900006483aa9830 | ||||
| EPA-R04-OAR-2018-0792-0003 | EPA | EPA-R04-OAR-2018-0792 | AL-SO2-Transport-SIP-Ozone-Part2 | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:40:43Z | 0 | 0 | 09000064838ea156 | ||||
| EPA-R04-OAR-2019-0156-0019 | EPA | EPA-R04-OAR-2019-0156 | AL-116-SIP Submittal-Admin-Part1 | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:41:07Z | 0 | 0 | 090000648425e167 | ||||
| EPA-R04-OAR-2018-0792-0001 | EPA | EPA-R04-OAR-2018-0792 | Air Quality State Implementation Plans; Approvals and Promulgations: Alabama; 2010 1-Hour SO2 NAAQS Transport Infrastructure | Proposed Rule | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2020-01-31T04:59:59Z | 2020-01-27T02:01:58Z | 2019-28236 | 0 | 0 | 090000648425d49a | |
| EPA-R04-OAR-2018-0792-0013 | EPA | EPA-R04-OAR-2018-0792 | 06-29-2016 2015 EMIS INV RPT | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:38:15Z | 0 | 0 | 09000064841f06a2 | ||||
| EPA-R09-OAR-2019-0598-0003 | EPA | EPA-R09-OAR-2019-0598 | Section 1 - Request for Coverage | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:41:50Z | 0 | 0 | 090000648425b000 | ||||
| EPA-R09-OAR-2019-0598-0005 | EPA | EPA-R09-OAR-2019-0598 | Section 3 – Supporting Documents | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:42:32Z | 0 | 0 | 090000648425bb1a | ||||
| EPA-R04-OAR-2019-0156-0020 | EPA | EPA-R04-OAR-2019-0156 | SC_Ozone_iSIP_20180907 | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:40:55Z | 0 | 0 | 090000648425e1b4 | ||||
| EPA-R08-OAR-2018-0380-0011 | EPA | EPA-R08-OAR-2018-0380 | Email Notif Final Permit to Permittee | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:41:20Z | 0 | 0 | 090000648425eb6a | ||||
| EPA_FRDOC_0001-24895 | EPA | EPA_FRDOC_0001 | Meetings: Chartered Science Advisory Board | Notice | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2020-01-18T04:59:59Z | 2020-01-18T02:03:03Z | 2019-28012 | 0 | 0 | 090000648425d44d | |
| EPA-R06-OAR-2018-0705-0013 | EPA | EPA-R06-OAR-2018-0705 | NM079.13 Proposed rule; extension of comment period; Air Quality State Implementation Plans; Approvals and Promulgations: New Mexico; Interstate Transport Requirements for the 2008 Ozone National Ambient Air Quality Standards (NAAQS), 1 page. | Proposed Rule | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2020-01-18T04:59:59Z | 2020-01-18T02:00:50Z | 2019-27865 | 0 | 0 | 090000648425d4e8 | |
| EPA-R04-OAR-2018-0792-0004 | EPA | EPA-R04-OAR-2018-0792 | AL-SO2-Transport-SIP-SO2part-Part3 | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:40:18Z | 0 | 0 | 09000064838ea157 | ||||
| EPA-HQ-OPP-2013-0153-0044 | EPA | EPA-HQ-OPP-2013-0153 | Environmental Chemistry Methods (ECM) and Independent Laboratory Validation (ILV) for Chloropicrin Data Evaluation Records (DERs) | Supporting & Related Material | Evaluation | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:35:24Z | 0 | 0 | 0900006483aa9831 | |||
| EPA-R04-OAR-2018-0792-0005 | EPA | EPA-R04-OAR-2018-0792 | June 6 2019 ADEM Email | Supporting & Related Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-01T01:40:06Z | 0 | 0 | 0900006483db751c | ||||
| FDA-2019-H-6024-0001 | FDA | FDA-2019-H-6024 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T15:24:25Z | 0 | 0 | 090000648425dd71 | ||
| FDA-2011-N-0902-0014 | FDA | FDA-2011-N-0902 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:53:14Z | 2019-28249 | 0 | 0 | 090000648425db88 | |
| FDA-2019-H-6009-0001 | FDA | FDA-2019-H-6009 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T15:23:23Z | 0 | 0 | 090000648425d8b7 | ||
| FDA-2019-P-6100-0004 | FDA | FDA-2019-P-6100 | Attachment C- The Classic Reprint: The Use and Uses of Large Split Skin Grafts of Intermediate Thickness re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:18:17Z | 0 | 0 | 090000648425e4dd | |||
| FDA-2019-P-6100-0005 | FDA | FDA-2019-P-6100 | Attachment D- 50 Years of Burn Care at Shriners Hospitals for Children, Galveston re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:18:30Z | 0 | 0 | 090000648425e4de | |||
| FDA-2019-P-6100-0002 | FDA | FDA-2019-P-6100 | Attachment A- The Classic Reprint re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:15:06Z | 0 | 0 | 090000648425e4db | |||
| FDA-2019-P-6099-0001 | FDA | FDA-2019-P-6099 | Citizen Petition from George M. Stone on behalf of Patients for Access to Advanced Therapy for Hemophilia | Other | Citizen Petition | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2024-11-12T23:15:15Z | 1 | 0 | 090000648425e1d0 | ||
| FDA-2019-P-6100-0009 | FDA | FDA-2019-P-6100 | Attachment H- Pelvic, Abdominal, and Chest Wall Reconstruction with Allo Derm in Patients at Increased Risk for Mesh-Related Complications re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:19:20Z | 0 | 0 | 090000648425e54c | |||
| FDA-2019-P-6100-0008 | FDA | FDA-2019-P-6100 | Attachment G- Sterile Decellularized Dermis - Instructions for Use re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:19:07Z | 0 | 0 | 090000648425e54b | |||
| FDA-2018-N-4839-0003 | FDA | FDA-2018-N-4839 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:56:25Z | 2019-28249 | 0 | 0 | 090000648425d8b1 | |
| FDA-2013-N-0662-0009 | FDA | FDA-2013-N-0662 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:53:40Z | 2019-28249 | 0 | 0 | 090000648425db89 | |
| FDA-2019-N-5955-0001 | FDA | FDA-2019-N-5955 | International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; AB-FUBINACA; 5FAMB- PINACA; 5F-MDMB-PICA; 4-FMDMB- BINACA; 4-CMC; Nethylhexedrone; alpha-PHP; DOC; Crotonyl Fentanyl; Valeryl Fentanyl; Flualprazolam and Etizolam; Request for Comments | Notice | Request for Comments | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2020-01-31T04:59:59Z | 2020-02-01T02:02:04Z | 2019-28269 | 0 | 0 | 090000648425d40c |
| FDA-2018-D-1459-0047 | FDA | FDA-2018-D-1459 | Food Labeling: Serving Sizes of Foods That Can Reasonably Be Consumed at One Eating Occasion, Reference Amounts Customarily Consumed, Serving Size-Related Issues, Dual- Column Labeling, and Miscellaneous Topics; Guidance for Industry; Availability | Rule | Notice of Interim Rule | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T15:10:26Z | 2019-27868 | 0 | 0 | 090000648425d410 | |
| FDA-2019-P-3877-0003 | FDA | FDA-2019-P-3877 | Determination That GLUCOPHAGE (Metformin Hydrochloride) Oral Tablets, 500 Milligrams, 850 Milligrams, and 1 Gram, and GLUCOPHAGE XR (Metformin Hydrochloride) Oral Extended-Release Tablets, 500 Milligrams and 750 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:31:28Z | 2019-28270 | 0 | 0 | 090000648425d320 | |
| FDA-2019-V-6101-0001 | FDA | FDA-2019-V-6101 | Variance Application from Donovan Rosling Rosling | Other | Application for Variance (VAR) | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T19:37:37Z | 0 | 0 | 090000648425ea93 | ||
| FDA-2019-H-6023-0001 | FDA | FDA-2019-H-6023 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T15:21:50Z | 0 | 0 | 090000648425db8b | ||
| FDA-2019-V-6101-0002 | FDA | FDA-2019-V-6101 | Acknowledgment Letter from FDA DMS to Donovan Rosling Rosling | Other | Acknowledgement Letter/Receipt | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T19:40:18Z | 0 | 0 | 090000648425eaab | ||
| FDA-2019-H-6021-0001 | FDA | FDA-2019-H-6021 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T19:37:18Z | 0 | 0 | 090000648425e0c7 | ||
| FDA-2019-P-6100-0001 | FDA | FDA-2019-P-6100 | Citizen Petition from American Association of Tissue Banks | Other | Citizen Petition | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2022-08-25T19:59:25Z | 0 | 0 | 090000648425e332 | ||
| FDA-2019-P-6100-0015 | FDA | FDA-2019-P-6100 | Attachment R- The use of a cellular dermal matrix in breast reconstruction evolution of techniques over 2 decades re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:22:44Z | 0 | 0 | 090000648425e552 | |||
| FDA-2019-P-6100-0003 | FDA | FDA-2019-P-6100 | Attachment B- Early Care of Burns re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:15:26Z | 0 | 0 | 090000648425e4dc | |||
| FDA-2019-P-6100-0011 | FDA | FDA-2019-P-6100 | Attachments J Through N re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:21:10Z | 0 | 0 | 090000648425e54e | |||
| FDA-2019-P-6100-0007 | FDA | FDA-2019-P-6100 | Attachment F- Decellularization Strategies for Regenerative Medicine: From Processing Techniques to Applications re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:18:55Z | 0 | 0 | 090000648425e4e0 | |||
| FDA-2019-P-6100-0010 | FDA | FDA-2019-P-6100 | Attachment I- Efficacy and safety of acellular dermal matrix in diabetic foot ulcer treatment: A systematic review and meta-analysis re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:20:08Z | 0 | 0 | 090000648425e54d | |||
| FDA-2019-P-6100-0012 | FDA | FDA-2019-P-6100 | Attachment O- Achilles Tendon Augmented Repair Using Human Acellular Dermal Matrix: A Case Series re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:22:03Z | 0 | 0 | 090000648425e54f | |||
| FDA-2019-N-0549-0011 | FDA | FDA-2019-N-0549 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:54:45Z | 2019-28249 | 0 | 0 | 090000648425d866 | |
| FDA-2016-N-3586-0005 | FDA | FDA-2016-N-3586 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Focus Groups About Drug Products as Used by the Food and Drug Administration | Notice | 30 Day Proposed Information Collection | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2020-01-31T04:59:59Z | 2019-12-31T14:36:48Z | 2019-28247 | 0 | 0 | 090000648425d323 |
| FDA-2019-H-5989-0001 | FDA | FDA-2019-H-5989 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T17:25:03Z | 0 | 0 | 090000648425e60c | ||
| FDA-2019-H-5984-0001 | FDA | FDA-2019-H-5984 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T16:44:31Z | 0 | 0 | 090000648425e092 | ||
| FDA-2019-H-5983-0001 | FDA | FDA-2019-H-5983 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T16:43:38Z | 0 | 0 | 090000648425e3cf | ||
| FDA-2019-H-5411-0001 | FDA | FDA-2019-H-5411 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:29:24Z | 0 | 0 | 090000648425d957 | ||
| FDA-2019-V-6105-0001 | FDA | FDA-2019-V-6105 | Variance Application from ETS Pro Lighting INC | Other | Application for Variance (VAR) | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T22:06:45Z | 0 | 0 | 090000648425f5f2 | ||
| FDA-2019-H-6006-0001 | FDA | FDA-2019-H-6006 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T16:42:40Z | 0 | 0 | 090000648425e37b | ||
| FDA-2019-H-5946-0001 | FDA | FDA-2019-H-5946 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T15:17:22Z | 0 | 0 | 090000648425e139 | ||
| FDA-2019-P-6100-0018 | FDA | FDA-2019-P-6100 | Attachment U Part 1- The use of acellular dermal matrix in breast reconstruction: evolution of techniques over 2 decades re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:23:24Z | 0 | 0 | 090000648425e4f4 | |||
| FDA-2019-P-6100-0016 | FDA | FDA-2019-P-6100 | Attachment S- Market Recap: Q418/FY18 Market Recap: US Surgical Matrices re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:23:00Z | 0 | 0 | 090000648425e553 | |||
| FDA-2019-H-6011-0001 | FDA | FDA-2019-H-6011 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T15:43:34Z | 0 | 0 | 090000648425d8f5 | ||
| FDA-2019-P-3877-0004 | FDA | FDA-2019-P-3877 | Response Letter to Harman Finochem Limited Updated from FDA CDER | Other | Agency Response | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T19:24:26Z | 0 | 0 | 090000648425fa9c | ||
| FDA-2019-H-5988-0001 | FDA | FDA-2019-H-5988 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T15:56:53Z | 0 | 0 | 090000648425e227 | ||
| FDA-2019-P-6100-0020 | FDA | FDA-2019-P-6100 | Attachment V Shuren Letter re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:23:57Z | 0 | 0 | 090000648425e4f6 | |||
| FDA-2019-P-6100-0019 | FDA | FDA-2019-P-6100 | Attachment U Part 2- Prepectoral Breast Reconstruction with Fenestrated Acellular Dermal Matrix: A Novel Design re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:23:45Z | 0 | 0 | 090000648425e4f5 | |||
| FDA-2013-N-0134-0149 | FDA | FDA-2013-N-0134 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:47:33Z | 2019-28249 | 0 | 0 | 090000648425d409 | |
| FDA-2013-N-0242-0015 | FDA | FDA-2013-N-0242 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:54:02Z | 2019-28249 | 0 | 0 | 090000648425db8d | |
| FDA-2019-P-6099-0002 | FDA | FDA-2019-P-6099 | Acknowledgment Letter from FDA DMS to George M. Stone | Other | Acknowledgement Letter/Receipt | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2020-08-05T19:12:41Z | 0 | 0 | 090000648425e1d2 | ||
| FDA-2019-H-5987-0001 | FDA | FDA-2019-H-5987 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T15:20:45Z | 0 | 0 | 090000648425db34 | ||
| FDA-2019-H-6012-0001 | FDA | FDA-2019-H-6012 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T19:36:06Z | 0 | 0 | 090000648425dde9 | ||
| FDA-2019-H-5985-0001 | FDA | FDA-2019-H-5985 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:28:56Z | 0 | 0 | 090000648425d6c8 | ||
| FDA-2019-P-6100-0021 | FDA | FDA-2019-P-6100 | Acknowledgment Letter from FDA DMS to American Association of Tissue Banks | Other | Acknowledgement Letter/Receipt | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2020-01-02T14:23:18Z | 0 | 0 | 090000648425dfef | ||
| FDA-2019-P-6100-0017 | FDA | FDA-2019-P-6100 | Attachment T AATB Letter re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:23:12Z | 0 | 0 | 090000648425e554 | |||
| FDA-2019-N-1517-0005 | FDA | FDA-2019-N-1517 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:54:26Z | 2019-28249 | 0 | 0 | 090000648425d865 | |
| FDA-2012-N-0477-0011 | FDA | FDA-2012-N-0477 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:55:36Z | 2019-28249 | 0 | 0 | 090000648425d86a | |
| FDA-2016-D-2565-0018 | FDA | FDA-2016-D-2565 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T14:56:03Z | 2019-28249 | 0 | 0 | 090000648425d8ae | |
| FDA-2013-N-0719-0008 | FDA | FDA-2013-N-0719 | Guidance for Industry on Planning for the Effects of High Absenteeism To Ensure Availability of Medically Necessary Drug Products | Other | Guidance | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2024-11-12T23:15:15Z | 1 | 0 | 090000648425e08e | ||
| FDA-2019-H-5986-0001 | FDA | FDA-2019-H-5986 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T15:19:25Z | 0 | 0 | 090000648425d794 | ||
| FDA-2016-N-4319-0004 | FDA | FDA-2016-N-4319 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Unique Device Identification System | Notice | General Notice | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2020-01-31T04:59:59Z | 2020-01-20T02:01:08Z | 2019-28246 | 0 | 0 | 090000648425d412 |
| FDA-2019-P-6100-0006 | FDA | FDA-2019-P-6100 | Attachment E- The US Navy Tissue Bank: 50 years on the cutting edge RE: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:18:42Z | 0 | 0 | 090000648425e4df | |||
| FDA-2019-V-6105-0002 | FDA | FDA-2019-V-6105 | Acknowledgment Letter from FDA DMS to ETS Pro Lighting INC | Other | Acknowledgement Letter/Receipt | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T22:12:06Z | 0 | 0 | 090000648425f5f3 | ||
| FDA-2019-H-6005-0001 | FDA | FDA-2019-H-6005 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T17:31:45Z | 0 | 0 | 090000648425eaf3 | ||
| FDA-2019-H-6022-0001 | FDA | FDA-2019-H-6022 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T17:02:47Z | 0 | 0 | 090000648425e4c9 | ||
| FDA-2019-H-6007-0001 | FDA | FDA-2019-H-6007 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T15:55:45Z | 0 | 0 | 090000648425e289 | ||
| FDA-2019-H-6020-0001 | FDA | FDA-2019-H-6020 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T16:59:40Z | 0 | 0 | 090000648425e019 | ||
| FDA-2019-H-6025-0001 | FDA | FDA-2019-H-6025 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T16:45:46Z | 0 | 0 | 090000648425e458 | ||
| FDA-2019-H-6026-0001 | FDA | FDA-2019-H-6026 | Complaint | Other | Complaint | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2019-12-31T16:46:40Z | 0 | 0 | 090000648425e50c | ||
| FDA-2019-N-0305-0005 | FDA | FDA-2019-N-0305 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-12-31T05:00:00Z | 2019 | 12 | 2019-12-31T05:00:00Z | 2022-10-14T13:05:41Z | 2019-28249 | 0 | 0 | 090000648425d867 | |
| FDA-2019-P-6100-0013 | FDA | FDA-2019-P-6100 | Attachment P- A Randomized controlled trial comparing a human acellular dermal matrix versus conventional care for the treatment of venous leg ulcers re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:22:17Z | 0 | 0 | 090000648425e550 | |||
| FDA-2019-P-6100-0014 | FDA | FDA-2019-P-6100 | Attachment Q- Clinical Evaluation of Acellular Allograft Dermis for the Treatment of Human Gingival Recession re: Citizen Petition from American Association of Tissue Banks | Supporting & Related Material | Background Material | 2019-12-31T05:00:00Z | 2019 | 12 | 2020-01-06T20:22:29Z | 0 | 0 | 090000648425e551 | |||
| FDA-2018-D-1459-0048 | FDA | FDA-2018-D-1459 | Food Labeling: Serving Sizes of Foods That Can Reasonably Be Consumed At One Eating Occasion, Reference Amounts Customarily Consumed, Serving Size-Related Issues, Dual-Column Labeling, and Miscellaneous Topics: Guidance for Industry | Other | 2019-12-31T00:00:00Z | 2019 | 12 | 2020-01-02T20:34:48Z | 0 | 1 | 090000648425e091 | ||||
| EPA_FRDOC_0001-24893 | EPA | EPA_FRDOC_0001 | Underground Injection Control Program; Hazardous Waste Injection Restrictions; Petition for Exemption Reissuance-Class I Hazardous Waste Injection: Great Lakes Chemical Corporation El Dorado, Arkansas Facility | Notice | 2019-12-30T05:00:00Z | 2019 | 12 | 2019-12-30T05:00:00Z | 2019-12-30T12:41:42Z | 2019-28209 | 0 | 0 | 0900006484256df8 | ||
| EPA-HQ-OPPT-2019-0131-0026 | EPA | EPA-HQ-OPPT-2019-0131 | High-Priority Substance Designations Under the Toxic Substances Control Act and Initiation of Risk Evaluation on High-Priority Substances; Availability | Notice | 2019-12-30T05:00:00Z | 2019 | 12 | 2019-12-30T14:40:29Z | 2019-28225 | 0 | 0 | 0900006484256f8d | |||
| EPA-R09-OAR-2019-0321-0007 | EPA | EPA-R09-OAR-2019-0321 | A6. Sup.Table 1. Major Sources of NOx and VOC in Maricopa County | Supporting & Related Material | 2019-12-30T05:00:00Z | 2019 | 12 | 2019-12-31T01:51:33Z | 0 | 0 | 09000064842158b2 | ||||
| EPA-R09-OAR-2019-0321-0008 | EPA | EPA-R09-OAR-2019-0321 | A7. Rule 324 Comment Response Support_8_28_2017 | Supporting & Related Material | 2019-12-30T05:00:00Z | 2019 | 12 | 2019-12-31T01:51:45Z | 0 | 0 | 09000064842158b3 | ||||
| EPA-R09-OAR-2019-0321-0027 | EPA | EPA-R09-OAR-2019-0321 | D5. Mojave Desert AQMD Rule 1157 | Supporting & Related Material | 2019-12-30T05:00:00Z | 2019 | 12 | 2019-12-31T01:48:22Z | 0 | 0 | 09000064842159b1 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);